menu_book

Current Affairs Pulse

Science & Tech22 Apr 2026

India Boosts Precision Medicine & Drug Discovery with New Policies and ₹5,000 Cr PRIP Scheme

8 sections below — scroll or usetocto jump
  • 1

    India is shifting focus from generic drug manufacturing to high-value innovation in medicine.

  • 2

    The government has launched the National Policy on Research and Development (2023) and the ₹5,000 crore PRIP scheme.

  • 3

    The Bio-E3 Policy (2024) and modernised clinical trial rules aim to create a self-reliant ecosystem for drug discovery.

  • 4

    The initiative targets indigenous design and manufacturing of precision medicine, particularly for rare genetic disorders.

  • India's new focus: High-value innovation in medicine, moving beyond generic manufacturing.
  • Key Policies: National Policy on Research and Development (2023) and Bio-E3 Policy (2024).
  • Key Scheme: PRIP scheme, allocated ₹5,000 crore for Pharma-MedTech R&D.
  • Strategic Goal: Building a self-reliant ecosystem for cutting-edge drug discovery and precision medicine.
  • Specific Application: Addressing rare genetic disorders through fundamental research.

Precision Medicine

Precision medicine is an innovative medical approach that tailors disease treatment and prevention strategies to individual patients, considering their unique genetic makeup, environmental factors, and lifestyle. This allows for more accurate prediction of which treatments will be effective for specific groups of people, moving beyond a 'one-size-fits-all' approach.

Simple Analogy: Instead of giving everyone the same standard medicine, precision medicine is like a tailor making a custom suit for each person, ensuring the perfect fit and effectiveness based on their unique biological measurements.

National Policy on Research and Development (2023)

To promote and support fundamental research and innovation across various sectors, including healthcare, fostering a robust R&D ecosystem.

Key: Aims to transition India towards high-value innovation from generic manufacturing.

PRIP scheme (Promoting Research and Innovation in Pharma-MedTech Sector)

To provide financial support for research and development activities in the pharmaceutical and medical technology sectors.

Key: Allocated ₹5,000 crore to boost indigenous innovation and self-reliance in these critical areas.

Bio-E3 Policy (2024)

To foster a self-reliant ecosystem for cutting-edge drug discovery and precision medicine in India.

Key: Likely focuses on enabling infrastructure, regulatory support, and funding mechanisms for biotechnology and biomedical research.

These initiatives are crucial for India to evolve from a global leader in generic drug manufacturing to a hub for high-value, innovative drug discovery and development. This strategic shift addresses the critical need for indigenous solutions, particularly for complex conditions like rare genetic disorders, thereby reducing reliance on foreign technologies. It aligns with the 'Atmanirbhar Bharat' vision by fostering self-reliance in the vital healthcare sector and positions India as a significant player in the global precision medicine market, ultimately improving public health outcomes.

Atmanirbhar Bharat Abhiyan

The policies and schemes directly support the 'Self-Reliant India' vision by promoting indigenous research, development, and manufacturing in the healthcare sector.

Biotechnology Sector in India

These initiatives are expected to significantly boost the growth, innovation capabilities, and global competitiveness of India's biotechnology and pharmaceutical industries.

Public Health & Rare Diseases

The development of precision medicine can lead to more effective and targeted treatments for various diseases, including rare genetic disorders, thereby improving overall public health.

Exam Relevance

upsc

GS-III (Science & Technology – Developments and their applications, Indigenization of technology, Bio-technology); GS-II (Government Policies and Interventions for Development in various sectors).

ssc

General Science, Current Affairs (Government schemes, policies).

banking

General Awareness (Government schemes, economic policies related to industry).

defence

General Science, Current Affairs (broader national development initiatives).

Previously Asked (PYQs)

UPSC_PRELIMS 2022

Consider the following statements : 1. The India Sanitation Coalition is a platform to promote sustainable sanitation and is funded by the Government of India and the World Health Organization. 2. The National Institute of Urban Affairs is an apex body of the Ministry of Housing and Urban Affairs in Government of India and provides innovative solutions to address the challenges of Urban India. Which of the statements given above is/are correct?

Answer: 2 only

UPSC_PRELIMS 2019

Consider the following statements about Particularly Vulnerable Tribal Groups (PVTGs) in India: 1. PVTGs reside in 18 States and one Union Territory. 2. A stagnant or declining population is one of the criteria for determining PVTG status. 3. There are 95 PVTGS officially notified in the country so far. 4. Irular and Konda Reddi tribes are included in the list of PVTGs. Which of the statements given above are correct?

Answer: 1, 2 and 4

UPSC_PRELIMS 2017

The object of the Butler Committee of 1927 was to

Answer: Improve the relationship between the Government of India and the Indian States.

Expected Questions

  • UPSC may ask: 'Consider the following statements regarding India's recent initiatives in precision medicine and drug discovery...' (statement-based on policies, funding, objectives, and their implications).
  • SSC may ask: 'What is the primary objective of the PRIP scheme?' (direct factual).
  • Banking may ask: 'What is the allocated fund for the PRIP scheme, aimed at promoting research and innovation in the Pharma-MedTech sector?' (numerical factual).

historyTopic Frequency

Medium-High for UPSC (Science & Tech, Government Schemes); Medium for SSC/Banking (Current Affairs).

Key Terms

Precision Medicine

A medical model that customizes healthcare, with decisions and treatments tailored to each individual patient.

Rare Genetic Disorders

Diseases caused by genetic mutations, affecting a small percentage of the population, often requiring specialized research and treatment.

Self-reliant Ecosystem

A system capable of sustaining itself without external dependence, particularly in technology, innovation, and manufacturing.

priority_highMust Remember

  • The National Policy on Research and Development (2023) and Bio-E3 Policy (2024) are key frameworks.
  • The PRIP scheme has a significant allocation of ₹5,000 crore.
  • The core objective is to shift from generic manufacturing to high-value innovation and self-reliance in drug discovery.

tips_and_updatesExam Tips

  • Pay close attention to the year of policy implementation, specific financial allocations, and the core objectives of each scheme/policy.
  • Understand the conceptual difference between generic manufacturing and high-value innovation in the pharmaceutical sector.
  • Relate these initiatives to broader national goals like 'Atmanirbhar Bharat'.
Question 1 of 5Score: 0/0
Factual

Which of the following policies, introduced by the Government of India, specifically aims to foster a self-reliant ecosystem for cutting-edge drug discovery and precision medicine?